An International Benchmarking Collaboration: Measuring Outcomes for the Hypertensive Disorders of Pregnancy

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 10, 2007, Pages 794-800

  Thornton, Charlene ^a   Hennessy, Annemarie ^a,b   von Dadelszen, Peter ^c   Nishi, Corrine ^c   Makris, Angela ^a   Ogle, Robert ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Benchmarking; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; AUSTRALIA; BIRTH WEIGHT; BLOOD PRESSURE REGULATION; CANADA; CLINICAL INDICATOR; FEMALE; HUMAN; ICD-10; LUNG EDEMA; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTION; PROGNOSTIC ASSESSMENT; QUALITY CONTROL; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; COMPARATIVE STUDY; GESTATIONAL AGE; HEALTH CARE QUALITY; HYPERTENSION; INFANT MORTALITY; LOW BIRTH WEIGHT; MORTALITY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION;

BENCHMARKING; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULMONARY EDEMA; QUALITY INDICATORS, HEALTH CARE;

EID: 38449090001     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32643-3     Document Type: Article

References (30)

1. Gibberd B. Why attitudes to quality of care are changing. Aust Health Rev 2001, 24(3):5-6.
2. Fazzi R.A., Agoglia R.V., Harlow L. Benchmarking. It's the future. Caring 2002, 21(11):36-39.
3. Clarke R., Sucher T. Benchmarking for the competitive marketplace. J Ambul Care Manage 1999, 22(3):72-77.
4. Sofaer S., Gruman J., Connaughton S., Grier R., Maule C. Developing performance indicators that reflect an expanded view of health: findings from the use of an innovative methodology. Jt Comm J Qual Improv 2000, 26(4):189-201.
5. Sobo E.J., Andriese S., Stroup C., Morgan D., Kurtin P. Developing indicators for emergency medical services (EMS) system evaluation and quality improvement: a statewide demonstration and planning project. Jt Comm J Qual Improv 2001, 27(3):138-154.
6. Glance L., Osler T., Dick A. Evaluating trauma center quality: does the choice of the severity-adjustment model make a difference?. J Trauma 2005, 58:1265-1271.
7. Fischer A., LaCoursiere D., Barnard P., Bloebaum L., Varner M. Differences between hospitals in cesarean rates for term primigravidas with cephalic presentation. Obstet Gynecol 2005, 105:816-821.
8. National Health Minister's Benchmarking Working Group 1996 First National Report on health sector performance indicators: public hospitals-the state of play 1996, Australian Institute of Health and Welfare, Canberra.
9. Ford J., Nassar N., Sullivan E.A., Chambers G., Lancaster P. Reproductive Health Indicators Australia 2002 2003, Canberra, Australian Institute of Health and Welfare.
10. Taylor L., Travis S., Pym M., Olive E., Henderson-Smart D. How useful are hospital morbidity data for monitoring conditions occurring in the perinatal period?. Aust N Z J Obstet Gynaecol 2005, 45:36-41.
11. NSW Department of Health Validation Study: NSW Midwives Data Collection 1998 2000, NSW Department of Health.
12. National Centre for Classification in Health The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian modification (ICD-10-AM) 1998, National Centre for Classification in Health, Faculty of Health Sciences, University of Sydney, Sydney.
13. Thornton C., Hennessy A., Makris A., Ogle R. Generic database systems are unreliable for reporting the hypertensive disorders of pregnancy. Aust N Z J Obstet Gynaecol 2004, 44:505-509.
14. GBD 2002 estimates. Geneva: World Health Organisation [updated 2003 Sep 4; cited 2005 Sep 19]. Available at: . Accessed June 28, 2007. http://www3.who.int/whosis/menu.cfm?path=whosis,burden,burden_estimates&language=english.
15. The Magpie Trial Collaborative Group Do women with preeclampsia and their babies benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet 2002, 359:1877-1890.
16. Davis G.K., Homer C.S., Brown M.A. Hypertension in pregnancy: do consensus statements make a difference?. Aust N Z J Obstet Gynaecol 2002, 42(4):369-373.
17. Brown M.A., Hague W., Higgins J., et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 2000, 40(2):133-138.
18. Baker D.F., Marks G.B., Poulos L.M., Williamson M. Review of Proposed National Health Priority Area: Asthma Indicators and Data Sources 2004, Australian Institute of Health and Welfare, Canberra.
19. Australian Institute of Health and Welfare Indicators of Health Risk: The AIHW View 2003, Australian Institute of Health and Welfare, Canberra.
20. The Australian Council of Healthcare Standards ACHS Clinical Indicator Users' Manual 2003, ACHS, Ultimo.
21. Helewa M.E., Burrows R.F., Smith J., Williams K., Brain P., Rabkin S.W. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997, 157:715-725.
22. Beeby P.J., Bhuta T., Taylor L.K. NSW population-based birth-weight percentile charts. J Paed Child Health. 1996, 32:512-518.
23. Butters L., Kennesy S., Rubin P.C. Atenolol in essential hypertension during pregnancy. BMJ 1990, 301:587-589.
24. Lip G.Y., Beevers M., Churchill D., Shaffer L.M., Beevers D.G. Effect of Atenolol on birth weight. Am J Cardiol 1997, 79:1436-1438.
25. Barr M.J.R., Cohen M.M. Ace inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 1991, 44:485-495.
26. Horvath J.S., Phippard A., Korda A., Henderson-Smart D.J., Child A., Tiller D.J. Clonidine hydrochloride-a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1985, 66:634-638.
27. Rey E., LeLorier J., Burgess E., Lange I.R., Leduc L. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997, 157:1245-1254.
28. Abalos E., Duley L., Steyn D.W., Henderson-Smart D.J. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. The Cochrane Database of Systematic Reviews 2001, 1.
29. Magee L.A., Ornstein M.P., von Dadelszen P. Clinical review: management of mild to moderate pregnancy hypertension. BMJ. 1999, 318:1332-1338.
30. von Dadelszen P., Ornstein M.P., Bull S.B., Logan A.G., Koren G., Magee L.A. Fall in arterial blood pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000, 355:87-92.